• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症影响量表(MSIS - 29)是一种可靠且灵敏的测量工具。

The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure.

作者信息

McGuigan C, Hutchinson M

机构信息

Department of Neurology, University College Dublin and St Vincent's University Hospital, Dublin, Ireland.

出版信息

J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):266-9.

PMID:14742602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1738881/
Abstract

OBJECTIVE

The aim of this study was to assess the psychometric properties of the Multiple Sclerosis Impact Scale (MSIS-29) for patients in the community and in a hospital setting.

METHODS

During an epidemiological study, 172 people with multiple sclerosis (MS) were examined and completed the MSIS-29, the London Handicap Scale, and Beck's Depression Inventory; disability was assessed by the Kurtzke Expanded Disability Status Score (EDSS) and the Multiple Sclerosis Functional Composite. At the hospital neurology clinic, 102 MS patients completed the MSIS-29 and EDSS assessments were performed; 41 of these patients had repeat evaluations six months later. The psychometric properties of the MSIS-29 were examined.

RESULTS

In the 172 community and the 102 hospital patients the psychometric properties of the MSIS-29 were satisfactory, with high convergent and low divergent validity. It was significantly responsive to change in the contexts of self-reported change (p<0.034) and EDSS worsening (p<0.001). The MSIS-29 physical score did not change over time when the EDSS was stable, and increased significantly in proportion to EDSS deterioration (p = 0.014).

CONCLUSIONS

The psychometric properties of the MSIS-29 are acceptable; it is a valuable outcome measure in intervention studies of patients with MS.

摘要

目的

本研究旨在评估社区和医院环境中多发性硬化症患者的多发性硬化症影响量表(MSIS - 29)的心理测量特性。

方法

在一项流行病学研究中,对172名多发性硬化症(MS)患者进行了检查,并让他们完成了MSIS - 29、伦敦残疾量表和贝克抑郁量表;通过库茨克扩展残疾状态评分(EDSS)和多发性硬化症功能综合评分来评估残疾情况。在医院神经科门诊,102名MS患者完成了MSIS - 29评估并进行了EDSS评估;其中41名患者在6个月后进行了重复评估。对MSIS - 29的心理测量特性进行了检查。

结果

在172名社区患者和102名医院患者中,MSIS - 29的心理测量特性令人满意,具有高收敛效度和低发散效度。在自我报告的变化(p < 0.034)和EDSS恶化(p < 0.001)的情况下,它对变化有显著反应。当EDSS稳定时,MSIS - 29身体评分随时间没有变化,并且与EDSS恶化成比例显著增加(p = 0.014)。

结论

MSIS - 29的心理测量特性是可接受的;它是MS患者干预研究中有价值的结果指标。

相似文献

1
The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure.多发性硬化症影响量表(MSIS - 29)是一种可靠且灵敏的测量工具。
J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):266-9.
2
[Validation of selected aspects of psychometry of the Polish version of the Multiple Sclerosis Impact Scale 29 (MSIS-29)].[波兰版多发性硬化症影响量表29(MSIS - 29)心理测量学特定方面的验证]
Neurol Neurochir Pol. 2007 May-Jun;41(3):215-22.
3
Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study.经检验与验证:基于人群研究中多发性硬化症影响量表(MSIS - 29)的心理测量特性。
Mult Scler. 2009 Jan;15(1):75-80. doi: 10.1177/1352458508096872. Epub 2008 Oct 1.
4
Responsiveness of the Multiple Sclerosis Impairment Scale in comparison with the Expanded Disability Status Scale.与扩展残疾状况量表相比,多发性硬化症损伤量表的反应性。
Mult Scler. 2005 Feb;11(1):81-4. doi: 10.1191/1352458505ms1120oa.
5
Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.多发性硬化症影响量表(MSIS - 29):与既定的损伤和残疾测量方法的关系
Mult Scler. 2004 Oct;10(5):569-74. doi: 10.1191/1352458504ms1078oa.
6
The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical).患者最有发言权:多发性硬化症影响量表(MSIS - 29身体部分)身体方面的显著变化。
J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):841-4. doi: 10.1136/jnnp.2006.105759. Epub 2007 Mar 1.
7
Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use.用于代理报告的多发性硬化症影响量表(MSIS - 29)的心理测量学评估。
J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1677-81. doi: 10.1136/jnnp.2005.065227.
8
Comparison of patient-reported outcome measures in multiple sclerosis.多发性硬化症患者报告结局测量的比较。
Acta Neurol Scand. 2013 Aug;128(2):114-21. doi: 10.1111/ane.12083. Epub 2013 Feb 7.
9
Psychometric properties of the Croatian version of the depression, anxiety, and stress scale-21 and multiple sclerosis impact scale-29 in multiple sclerosis patients.克罗地亚语版抑郁、焦虑和压力量表-21以及多发性硬化症影响量表-29在多发性硬化症患者中的心理测量特性。
Mult Scler Relat Disord. 2021 May;50:102850. doi: 10.1016/j.msard.2021.102850. Epub 2021 Feb 20.
10
Psychometric properties of a Norwegian version of Multiple Sclerosis Impact Scale (MSIS-29).挪威语多发性硬化症影响量表(MSIS-29)的信度和效度研究。
Acta Neurol Scand. 2010 Oct;122(4):244-51. doi: 10.1111/j.1600-0404.2009.01298.x. Epub 2009 Nov 23.

引用本文的文献

1
Patient-reported outcomes of quality of life before and after autologous hematopoietic stem cell transplantation for multiple sclerosis.多发性硬化症自体造血干细胞移植前后患者报告的生活质量结果。
Mult Scler. 2025 Apr;31(4):455-463. doi: 10.1177/13524585251315363. Epub 2025 Feb 17.
2
Robotic Rigor: Validity of the Kinarm End-Point Robot Visually Guided Reaching Test in Multiple Sclerosis.机器人精确性:Kinarm 端点机器人视觉引导伸手测试在多发性硬化症中的有效性
Arch Rehabil Res Clin Transl. 2024 Nov 6;6(4):100382. doi: 10.1016/j.arrct.2024.100382. eCollection 2024 Dec.
3
Virtual reality-based neuroproprioceptive physiotherapy in multiple sclerosis: a protocol for a double-arm randomised assessor-blinded controlled trial on upper extremity function, postural function and quality of life, with molecular and functional MRI assessment.基于虚拟现实的多发性硬化症神经本体感觉物理治疗:一项关于上肢功能、姿势功能和生活质量的双臂随机评估者盲法对照试验方案,包括分子和功能磁共振成像评估。
BMJ Open. 2025 Jan 9;15(1):e088046. doi: 10.1136/bmjopen-2024-088046.
4
A machine learning approach to determine the risk factors for fall in multiple sclerosis.一种机器学习方法,用于确定多发性硬化症患者跌倒的风险因素。
BMC Med Inform Decis Mak. 2024 Jul 30;24(1):215. doi: 10.1186/s12911-024-02621-0.
5
Immersive VR for upper-extremity rehabilitation in patients with neurological disorders: a scoping review.沉浸式虚拟现实上肢康复治疗神经系统疾病患者:范围综述。
J Neuroeng Rehabil. 2024 May 11;21(1):75. doi: 10.1186/s12984-024-01367-0.
6
Variability of Multiple Sclerosis Walking Scale and Multiple Sclerosis Impact Scale Scores in People Without Multiple Sclerosis.无多发性硬化症人群的多发性硬化症步行量表及多发性硬化症影响量表评分的变异性
Cureus. 2024 Jan 7;16(1):e51811. doi: 10.7759/cureus.51811. eCollection 2024 Jan.
7
Shared Decision-Making in the Treatment of Multiple Sclerosis: Results of a Cross-Sectional, Real-World Survey in Europe and the United States.多发性硬化症治疗中的共同决策:欧美横断面真实世界调查结果
Patient Prefer Adherence. 2024 Jan 16;18:137-149. doi: 10.2147/PPA.S440410. eCollection 2024.
8
Health and wellbeing outcomes associated with loneliness for people with disability: a scoping review.残疾人群体孤独感与其健康和福利结果的关系:范围综述。
BMC Public Health. 2023 Nov 29;23(1):2361. doi: 10.1186/s12889-023-17101-9.
9
Establishing clinically meaningful within-individual improvement thresholds for eight patient-reported outcome measures in people with relapsing-remitting multiple sclerosis.确立复发缓解型多发性硬化患者 8 项患者报告结局测量指标的临床有意义个体内改善阈值。
J Patient Rep Outcomes. 2023 Jul 4;7(1):61. doi: 10.1186/s41687-023-00594-8.
10
Diet, Physical Activity, and Stress Among Wheelchair Users With Multiple Sclerosis: Examining Individual and Co-Occurring Behavioral Risk Factors.饮食、身体活动和多发性硬化症轮椅使用者的压力:个体和共同发生的行为风险因素的研究。
Arch Phys Med Rehabil. 2023 Apr;104(4):590-596.e1. doi: 10.1016/j.apmr.2022.12.194. Epub 2023 Jan 14.

本文引用的文献

1
One year changes in disability in multiple sclerosis: neurological examination compared with patient self report.多发性硬化症患者残疾情况的一年变化:神经学检查与患者自我报告的比较
J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):439-42. doi: 10.1136/jnnp.74.4.439.
2
Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples.多发性硬化症影响量表(MSIS - 29):基于医院样本的信度和效度
J Neurol Neurosurg Psychiatry. 2002 Dec;73(6):701-4. doi: 10.1136/jnnp.73.6.701.
3
The SF-36 in multiple sclerosis: why basic assumptions must be tested.多发性硬化症中的SF-36:为何必须检验基本假设。
J Neurol Neurosurg Psychiatry. 2001 Sep;71(3):363-70. doi: 10.1136/jnnp.71.3.363.
4
The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.多发性硬化症影响量表(MSIS - 29):一种基于患者的新型结局指标。
Brain. 2001 May;124(Pt 5):962-73. doi: 10.1093/brain/124.5.962.
5
Kurtzke scales revisited: the application of psychometric methods to clinical intuition.再谈库尔茨克量表:心理测量方法在临床直觉中的应用
Brain. 2000 May;123 ( Pt 5):1027-40. doi: 10.1093/brain/123.5.1027.
6
MS functional composite: relation to disease phenotype and disability strata.
Neurology. 2000 Mar 28;54(6):1233-9. doi: 10.1212/wnl.54.6.1233.
7
Intrarater and interrater reliability of the MS functional composite outcome measure.MS功能综合结局指标的评估者内及评估者间信度
Neurology. 2000 Feb 22;54(4):802-6. doi: 10.1212/wnl.54.4.802.
8
A health-related quality of life questionnaire for multiple sclerosis patients.
Acta Neurol Scand. 1999 Sep;100(3):148-55. doi: 10.1111/j.1600-0404.1999.tb00730.x.
9
The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis.盖伊神经功能障碍量表(GNDS):一种针对多发性硬化症的新型功能障碍测量方法。
Mult Scler. 1999 Aug;5(4):223-33. doi: 10.1177/135245859900500406.
10
Development of a multiple sclerosis functional composite as a clinical trial outcome measure.开发一种多发性硬化功能综合指标作为临床试验结果测量指标。
Brain. 1999 May;122 ( Pt 5):871-82. doi: 10.1093/brain/122.5.871.